Prof. Orest Blaschuk's Prolific Patents in Cadherin Cell Adhesion Science

Prof Orest Blachuk of McGill University Dept. of Urology has racked up an impressive portfolio of patents and patent applications. He is cofounder of Adherex Technology and its scientific luminary. Adherex is on the path to some significant advances in cancer treatment prognoses.

1	US7138369	Compounds and methods for modulating apoptosis
2	US7122623	Compounds and methods for modulating cell adhesion
3	US20060183884	Compounds and methods for modulating cell adhesion
4	US7063842	Compounds and methods for inhibiting the interaction between .alpha.-catenin and .beta.-catenin
5	US6967238	Compounds and methods for modulating cell adhesion
6	US6962969	Compounds and methods for modulating nonclassical cadherin-mediated functions
7	US20050222037	Compounds and methods for modulating VE-cadherin-mediated function
8	US20050215482	Compounds and methods for modulating OB-cadherin-mediated function
9	US20050203025	Compounds and methods for modulating nonclassical cadherin-mediated functions
10	US-APP20050163786	Compounds and methods for modulating adhesion molecule function
11	US6914044	Compounds and methods for modulating cell adhesion
12	US20050129676	Compounds and methods for modulating functions of classical cadherins
13	US20050037973	Compounds and methods for cancer therapy
14	US20040254099	Compounds and methods for modulating beta-catenin mediated gene expression
15	US6830894	Compounds and methods for modulating claudin-mediated functions
16	US20040248219	Methods for diagnosing and evaluating cancer
17	US20040248220	Methods for diagnosing and evaluating cancer
18	US20040229811	Compounds and methods for modulating desmosomal cadherin-mediated functions
19	US6806255	Compounds and methods for modulating adhesion molecule function
20	US6797807	Compounds and methods for cancer therapy
21	US20040175361	Compounds and methods for modulating functions of nonclassical cadherins
22	US6780845	Compounds and methods for cancer therapy
23	US20040142854	Compounds and methods for stimulating beta-catenin mediated gene expression and differentiation
24	US20040132651	Compounds and methods for regulating cell adhesion
25	US6756356	Compounds and methods for modulating claudin-mediated functions
26	US20040106545	Compounds and methods for modulating cell adhesion
27	US6723700	Compounds and methods for modulating claudin-mediated functions
28	US20040058864	Peptidomimetic modulators of cell adhesion
29	US6706685	Compounds and methods for stimulating .beta.-catenin mediated gene expression and differentiation
30	US6682901	Methods for diagnosing and evaluating cancer
31	US6683048	Compounds and methods for stimulating gene expression and cellular differentiation
32	US6680175	Methods for diagnosing and evaluating cancer
33	US6677116	Methods for treating cancer by modulating .beta.-catenin mediated gene expression
34	US20040006011	Peptidomimetic modulators of cell adhesion
35	US20030236186	Compounds and methods for inhibiting the interaction between alpha-catenin and beta-catenin
36	US20030229199	Compounds and methods for modulating nonclassical cadherin-mediated functions
37	US20030224978	Compounds and methods for modulating apoptosis
38	US6638911	Compounds and methods for modulating desmosomal cadherin-mediated functions
39	US6610821	Compounds and methods for modulating endothelial cell adhesion
40	US6593297	Compounds and methods for inhibiting cancer metastasis
41	US20030109454	Compounds and methods for modulating adhesion molecule function
42	US6569996	Antibody that specifically binds to the cadherin-5 cell adhesion recognition sequence
43	US20030096746	Compounds and methods for inhibiting cancer metastasis
44	US6562786	Compounds and methods for modulating apoptosis
45	US20030087811	Compounds and methods for cancer therapy
46	US20030082166	Compounds and methods for modulating nonclassical cadherin-mediated functions
47	US6551994	Compounds and methods for inhibiting the interaction between .alpha.-catenin and .beta.-catenin
48	US20030065136	Compounds and methods for modulating cell adhesion
49	US20030027761	Compounds and methods for modulating junctional adhesion molecule-mediated functions
50	US20030013655	Compounds and methods for regulating cell adhesion

51	US20020193294	COMPOUNDS AND METHODS FOR MODULATING CLAUDIN-MEDIATED FUNCTIONS
52	US20020168761	Peptidomimetic modulators of cell adhesion
53	US20020169106	COMPOUNDS AND METHODS FOR INHIBITING CANCER METASTASIS
54	US6472368	Compounds and methods for modulating adhesion molecule function
55	US6472367	Compounds and methods for modulating OB-cadherin mediated cell adhesion
56	US20020151475	Compounds and methods for modulating cell adhesion
57	US6465427	Compounds and methods for modulating cell adhesion
58	US20020146687	METHODS FOR DIAGNOSING AND EVALUATING CANCER
59	US20020123044	METHODS FOR DIAGNOSING AND EVALUATING CANCER
60	US6433149	Compounds and methods for inhibiting cancer metastasis
61	US6417325	Compounds and methods for cancer therapy
62	US6391855	Compounds and methods for modulating junctional adhesion molecule-mediated functions
63	US6358920	Compounds and methods for modulating nonclassical cadherin-mediated functions
64	US6346512	Compounds and methods for modulating cell adhesion
65	US6333307	Compounds and method for modulating neurite outgrowth
66	US6326352	Compounds and methods for modulating cell adhesion
67	US6310177	Compounds and methods for modulating tissue permeability
68	US6303576	Compounds and methods for modulating .beta.-catenin mediated gene expression
69	US6277824	Compounds and methods for modulating adhesion molecule function
70	US6248864	Compounds and methods and modulating tissue permeability
71	US6207639	Compounds and methods for modulating neurite outgrowth
72	US6203788	Compounds and methods for regulating cell adhesion
73	US6169071	Compounds and methods for modulating cell adhesion
74	US6110747	Compounds and methods for modulating tissue permeability
75	US6031072	Compounds and methods for modulating cell adhesion

What a heck of a substantive patent portfolio.